Psyence Biomedical (PBM) Competitors $0.62 -0.01 (-1.97%) As of 01:27 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock PBM vs. PMCB, PHXM, TXMD, INDP, SLXN, GELS, APLM, NEUP, TRAW, and RLMDShould you be buying Psyence Biomedical stock or one of its competitors? The main competitors of Psyence Biomedical include PharmaCyte Biotech (PMCB), PHAXIAM Therapeutics (PHXM), TherapeuticsMD (TXMD), Indaptus Therapeutics (INDP), Silexion Therapeutics (SLXN), Gelteq (GELS), Apollomics (APLM), Neuphoria Therapeutics Inc. - Common Stock (NEUP), Traws Pharma (TRAW), and Relmada Therapeutics (RLMD). These companies are all part of the "pharmaceutical products" industry. Psyence Biomedical vs. PharmaCyte Biotech PHAXIAM Therapeutics TherapeuticsMD Indaptus Therapeutics Silexion Therapeutics Gelteq Apollomics Neuphoria Therapeutics Inc. - Common Stock Traws Pharma Relmada Therapeutics Psyence Biomedical (NASDAQ:PBM) and PharmaCyte Biotech (NASDAQ:PMCB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, earnings, valuation, institutional ownership, community ranking, media sentiment, analyst recommendations, dividends and profitability. Does the media prefer PBM or PMCB? In the previous week, Psyence Biomedical had 1 more articles in the media than PharmaCyte Biotech. MarketBeat recorded 3 mentions for Psyence Biomedical and 2 mentions for PharmaCyte Biotech. Psyence Biomedical's average media sentiment score of 1.27 beat PharmaCyte Biotech's score of 0.44 indicating that Psyence Biomedical is being referred to more favorably in the media. Company Overall Sentiment Psyence Biomedical Positive PharmaCyte Biotech Neutral Which has higher earnings & valuation, PBM or PMCB? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPsyence BiomedicalN/AN/A-$51.16MN/AN/APharmaCyte BiotechN/AN/A$330K$0.741.82 Which has more volatility and risk, PBM or PMCB? Psyence Biomedical has a beta of -0.45, suggesting that its stock price is 145% less volatile than the S&P 500. Comparatively, PharmaCyte Biotech has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Do insiders and institutionals believe in PBM or PMCB? 77.4% of Psyence Biomedical shares are held by institutional investors. Comparatively, 34.2% of PharmaCyte Biotech shares are held by institutional investors. 3.6% of Psyence Biomedical shares are held by insiders. Comparatively, 10.2% of PharmaCyte Biotech shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Does the MarketBeat Community believe in PBM or PMCB? Psyence Biomedical and PharmaCyte Biotech both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformPsyence BiomedicalN/AN/APharmaCyte BiotechN/AN/A Is PBM or PMCB more profitable? PharmaCyte Biotech's return on equity of 0.76% beat Psyence Biomedical's return on equity.Company Net Margins Return on Equity Return on Assets Psyence BiomedicalN/A N/A N/A PharmaCyte Biotech N/A 0.76%0.45% SummaryPharmaCyte Biotech beats Psyence Biomedical on 5 of the 8 factors compared between the two stocks. Remove Ads Get Psyence Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for PBM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PBM vs. The Competition Export to ExcelMetricPsyence BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.79M$6.86B$5.61B$7.73BDividend YieldN/A2.80%5.33%4.03%P/E RatioN/A7.3023.5418.61Price / SalesN/A205.12368.5788.89Price / CashN/A65.6738.1734.64Price / Book-0.016.166.784.10Net Income-$51.16M$142.11M$3.20B$247.18M7 Day Performance-5.06%-8.74%-5.60%-3.97%1 Month Performance-50.32%-10.41%-0.36%-6.37%1 Year Performance-99.28%-13.06%7.68%-2.04% Psyence Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PBMPsyence BiomedicalN/A$0.62-2.0%N/A-99.3%$2.79MN/A0.00N/AShort Interest ↓News CoveragePMCBPharmaCyte Biotech1.3569 of 5 stars$1.56-0.6%N/A-44.3%$10.71MN/A2.944Short Interest ↑Positive NewsPHXMPHAXIAM TherapeuticsN/A$3.10flatN/AN/A$10.58M$32.66M0.0049TXMDTherapeuticsMD0.8831 of 5 stars$0.91+5.4%N/A-57.1%$10.52M$1.60M0.00420Upcoming EarningsShort Interest ↓Gap DownINDPIndaptus Therapeutics3.7452 of 5 stars$0.71+8.0%$8.50+1,092.1%-73.7%$10.29MN/A-0.426High Trading VolumeSLXNSilexion TherapeuticsN/A$1.19+6.3%$5.00+320.2%N/A$10.01MN/A0.00N/AGap UpGELSGelteqN/A$1.06+1.4%N/AN/A$10.00MN/A0.00N/AAPLMApollomics2.5556 of 5 stars$9.10-4.2%$200.00+2,097.8%-89.8%$9.89M$1.22M0.0045News CoverageNEUPNeuphoria Therapeutics Inc. - Common Stock1.932 of 5 stars$5.52+2.2%$21.00+280.4%N/A$9.70M$662,715.000.00N/APositive NewsTRAWTraws Pharma1.1659 of 5 stars$2.65-6.7%N/AN/A$9.68M$226,000.00-0.0217Earnings ReportUpcoming EarningsNews CoverageRLMDRelmada Therapeutics3.8762 of 5 stars$0.32+6.1%$4.25+1,226.5%-93.6%$9.67MN/A-0.1110Earnings ReportGap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies PharmaCyte Biotech Alternatives PHAXIAM Therapeutics Alternatives TherapeuticsMD Alternatives Indaptus Therapeutics Alternatives Silexion Therapeutics Alternatives Gelteq Alternatives Apollomics Alternatives Neuphoria Therapeutics Inc. - Common Stock Alternatives Traws Pharma Alternatives Relmada Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PBM) was last updated on 3/31/2025 by MarketBeat.com Staff From Our PartnersA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredA brutally honest economic warning for 2025 (see proof)New York Times best-selling financial author and world-renowned economist Addison Wiggin (a man who’s worked s...Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Great Society Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Psyence Biomedical Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Psyence Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PBM Stock Free PBM Stock Alerts